Clinical Trials Browser

Phase 4 × gadolinium ethoxybenzyl DTPA × 90 days × Clear all

NCT04973007 2026-04-22

Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases

Phase 4 Terminated

Gastrointestinal

Colorectal Neoplasms

NCT04288323 2026-02-12

Gadolinium Contrast-enhanced Abbreviated MRI (AMRI) vs. Standard Ultrasound for Hepatocellular Carcinoma (HCC) Surveillance in Patients With Cirrhosis

Phase 4 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms